Press release
Personal Care
March 14, 2014

TEGO® Solve 61 – Naturally derived solubilizer for lipophilic& natural oils

Evonik launches a new PEG-free solubilizer for the effective solubilization of natural oils and lipophilic emollients.

TEGO® Solve 61, a high performance solubilizer optimized for the incorporation of lipophilic components into water-based formulations, is based on polyglyceryl esters and made from 100% renewable raw materials. Due to its cold processability and ease of handling, TEGO® Solve 61 facilitates the preparation of mixtures with oils and water. The PEG-free product can be used in various aqueous formulations, e.g. cleaning solutions or detergent systems, without affecting their foaming properties, and is suitable for natural cosmetics according to recognized standards (e.g. Ecocert).

TEGO® Solve 61 (proposed INCI: Polyglyceryl-6 Caprylate; Polyglyceryl-4 Caprate; Polyglyceryl-4 Cocoate; Polyglyceryl-6 Ricinoleate) is effective for the solubilization of very lipophilic ingredients like fatty or natural oils (e.g. jojoba, avocado, argan and sunflower oil). Crystal clear cosmetic formulations are possible. The product is cold processable without the formation of gel phases. TEGO® Solve 61 furthermore shows mitigating attributes as well as effective moisturization and skin feel benefits.

Evonik introduces TEGO® Solve 61, a highly effective PEG-free, naturally derived solubilizer for easy and versatile incorporation of natural fatty oils in various cosmetic formulations.

Company information

Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €2.0 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.